Bloomberg Law

GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales

GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and BioNTech have reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine technology.

Astellas Loses Bid to Block Myrbetriq Copies During Patent Suit

A federal judge rejected Astellas Pharma Inc.’s requests to block Lupin’s and Zydus’ copies of the overactive-bladder treatment Myrbetriq during a patent-infringement suit, finding an injunction in a related appeal doesn’t change the court’s assessment that Astellas is unlikely to overcome invalidity arguments.

Meta Denied Bid to Dismiss MyMeta’s Opposition to its Trademark

Meta Platforms Inc. failed to shake Italian-owned MyMeta Softawre Inc.'s attempt to block it from registering a “Meta” software trademark.

Molson Coors ‘Zima’ Trademark Expires, Mooting Cancellation Bid

Molson Coors Beverage Co. let the trademark for its once popular carbonated malt drink ‘Zima’ expire amid a brand revival company’s efforts cancel it. .

AI Copyright Bill Thrills Artists. Developers Call It Unworkable

A bill to require generative AI developers to disclose when they train their models on copyrighted works raises major logistical issues to go along with raging legal questions.

AI Trained on Famed Authors’ Copyrighted Work. They Want Revenge – Part 2

Latest Stories

ChatGPT and Generative AI Are Hits! Can Copyright Law Stop Them?

Could America's intellectual property laws spell doom for the burgeoning field of generative AI? This video explores the brewing battle over copyright and artificial intelligence.

AI Trained on Famed Authors’ Copyrighted Work. They Want Revenge – Part 2

AI Trained on Famed Authors’ Copyrighted Work. They Want Revenge – Part 1

The NIL Era: Paying NCAA Athletes Is Changing Sports

Would Reforming Section 230 Break the Internet?

From Across Bloomberg Law

Privacy & Data Security Law News Tech & Telecom Law News Business & Practice The United States Law Week
  • Privacy & Data Security Law News
  • Tech & Telecom Law News
  • Business & Practice
  • The United States Law Week

Darktrace Agrees to Sell to Thoma Bravo for $5.32 Billion (2)

UK cybersecurity company <-rte-company state="{"_id":"0000018f-1a03-d583-afbf-dadfd73f0000","_type":"00000160-4b23-d8bd-adfd-4b3348fd0000"}">Darktrace Plc agreed to sell itself to private equity firm <-bsp-bb-link state="{"bbHref":"bbg://securities/129626Z%20US%20Equity","_id":"0000018f-1a03-d583-afbf-dadfd73f0001","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Thoma Bravo for an equity value of about $5.32 billion.

IN BRIEF

View More

Case: Patents/Stay (W.D. Tex.)

The court granted Cisco Sytems Inc.'s motion to stay UMBRA Technologies Ltd. (UK), UMBRA Technologies Limited (CN), and UMBRA Technologies (US) Inc.'s action for infringement of three patents, pending inter partes review. Umbra Techs. Ltd. UK v. Cisco Sys. Inc., 2024 BL 142085, W.D. Tex., 1:23-CV-903-DII, 4/25/24

Case: Trademarks/Jurisdiction (D. Utah)

The court granted New Creation Brands’ motion to dismiss Rayware Ltd.’s trademark infringement claims on the grounds that the court lacks jurisdiction over the foreign defendant, because advertising products on a website wasn’t enough to satisfy the minimum contacts. Rayware Ltd. v. New Creations Brands, 2024 BL 140567, D. Utah, 2:23-cv-00355-DBB-DAO, 4/24/24

Case: Trade Secrets/Summary Judgment (9th Cir.)

The court affirmed a district court’s grant of summary judgment for Chattem Chemicals Inc. on H&H Pharmaceuticals LLC’s breach of contract claim and vacated the lower court’s ruling on H&H’s tort claims. H&H Pharms. LLC v. Chattem Chems. Inc., 2024 BL 138056, 9th Cir., 23-15055, unpublished, 4/23/24